Fentanyl Citrate | API DMFs | US Drug Master File (DMF) Details | Pharmacompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Fentanyl Citrate
USDMF

PharmaCompass Sponsored Ads

Contact Supplier

Veranova Fentanyl Citrate

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Fentanyl Citrate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

32 API Suppliers, 14 USDMF, 12 CEP/COS, 3 JDMF, 3 EU WC, 4 KDMF, 16 NDC API, 17 Listed Suppliers, $ API Reference Price

32 API Suppliers
14 USDMF
12 CEP/COS
3 JDMF
3 EU WC
4 KDMF
16 NDC API
17 Listed Suppliers
$ API Reference Price

FINISHED DOSAGE FORMULATIONS

279 FDF Dossiers, 77 FDA Orange Book, 159 Europe, 14 Canada, 3 South Africa, 26 Listed Dossiers

279 FDF Dossiers
77 FDA Orange Book
159 Europe
14 Canada
3 South Africa
26 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.2MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.4MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.6MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.8MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 1.2MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 1.6MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.1MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.2MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;BUCCAL, SUBLINGUAL - EQ 0.4MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.6MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.8MG BASE, TABLET;SUBLINGUAL - EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.2MG BASE
TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.4MG BASE
TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.6MG BASE
TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.8MG BASE
TROCHE/LOZENGE;TRANSMUCOSAL - EQ 1.2MG BASE
TROCHE/LOZENGE;TRANSMUCOSAL - EQ 1.6MG BASE
TABLET;BUCCAL, SUBLINGUAL - EQ 0.1MG BASE
TABLET;BUCCAL, SUBLINGUAL - EQ 0.2MG BASE
TABLET;BUCCAL, SUBLINGUAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;BUCCAL, SUBLINGUAL - EQ 0.4MG BASE
TABLET;BUCCAL, SUBLINGUAL - EQ 0.6MG BASE
TABLET;BUCCAL, SUBLINGUAL - EQ 0.8MG BASE
TABLET;SUBLINGUAL - EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;SUBLINGUAL - EQ 0.2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;SUBLINGUAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;SUBLINGUAL - EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;SUBLINGUAL - EQ 0.6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;SUBLINGUAL - EQ 0.8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SPRAY, METERED;NASAL - EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SPRAY, METERED;NASAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SPRAY, METERED;NASAL - EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 17 SPI Pharma, 1 Jai Radhe Sales, 2 Boai NKY Pharmaceuticals Ltd, 11 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 6 Actylis, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 BASF, 10 Corel Pharma Chem, 4 DFE Pharma, 1 Finar, 5 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 8 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

59 Fillers, Diluents & Binders, 42 Coating Systems & Additives, 34 Direct Compression, 28 Disintegrants & Superdisintegrants, 23 Controlled & Modified Release, 18 Thickeners and Stabilizers, 17 Taste Masking, 16 Granulation, 15 Chewable & Orodispersible Aids, 14 Co-Processed Excipients, 11 Lubricants & Glidants, 11 Film Formers & Plasticizers, 9 Parenteral, 5 Solubilizers, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 3 Emulsifying Agents, 3 Topical, 3 Rheology Modifiers, 2 Coloring Agents

59 Fillers, Diluents & Binders
42 Coating Systems & Additives
34 Direct Compression
28 Disintegrants & Superdisintegrants
23 Controlled & Modified Release
18 Thickeners and Stabilizers
17 Taste Masking
16 Granulation
15 Chewable & Orodispersible Aids
14 Co-Processed Excipients
11 Lubricants & Glidants
11 Film Formers & Plasticizers
9 Parenteral
5 Solubilizers
5 Empty Capsules
5 API Stability Enhancers
4 Vegetarian Capsules
3 Emulsifying Agents
3 Topical
3 Rheology Modifiers
2 Coloring Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 35 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
35 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 103 Finished Drug Prices

2 US Medicaid Prescriptions
103 Finished Drug Prices

MARKET PLACE

11 APIs, 5 FDF Dossiers

11 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

36 US Patents, 17 Health Canada Patents

36 US Patents
17 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 3 Others

2 EDQM
1 USP
3 Others

$ API Ref.Price (USD/KG) : 64,860 Xls

Filters

Reset all filters

Filters

FILTER :

filter Holder Reset all filters

14 All

01 1Veranova

02 1Abbott Laboratories

03 1Boehringer Ingelheim GmbH

04 2Cambrex Corporation

05 1Chattem Chemicals, Inc

06 1Cody Laboratories, Inc.

07 1Curia

08 1Fujifilm Diosynth Biotechnologies

09 2Mallinckrodt Pharmaceuticals

10 1Merck & Co

11 1Yichang Humanwell Pharmaceutical

12 1Blank

filter Subject Reset all filters

14 All

01 5FENTANYL CITRATE

02 1FENTANYL CITRATE (BULK)

03 1FENTANYL CITRATE (NEW PROCESS)

04 1FENTANYL CITRATE ACTIVE INGREDIENT

05 3FENTANYL CITRATE USP

06 1FENTANYL CITRATE USP MICRONIZED

07 1FENTANYL CITRATE, BULK FORM

08 1FENTANYL CITRATE, NON-STERILE BULK DRUG SUBSTANCE

filter Country Reset all filters

14 All

01 1China

02 1Germany

03 2Ireland

04 8U.S.A

05 1United Kingdom

06 1Blank

filter Status Reset all filters

14 All

01 5Active

02 9Inactive

filter GDUFA DMF Review Reset all filters

14 All

01 4Complete

02 10Blank

Aspen Fentanyl Citrate

List of Suppliers

Product Main Page

01

Veranova Lp

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Contact Supplier

Digital Content

Fentanyl Citrate (bulk)

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 5038

Submission : 1983-08-15

Status : Active

Type : II

Product Web Link

Digital Content

02

Abbott Pharmaceuticals Inc

USDMF

2024 ACI Convention

Not Confirmed

02

Abbott Pharmaceuticals Inc

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Fentanyl Citrate

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 8279

Submission : 1989-11-02

Status : Inactive

Type : II

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Cambrex Charles City Inc

USDMF

2024 ACI Convention

Not Confirmed

03

Cambrex Charles City Inc

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Fentanyl Citrate Usp

GDUFA

DMF Review : Complete

Rev. Date : 2013-02-12

Pay. Date : 2013-01-23

DMF Number : 17055

Submission : 2003-12-19

Status : Active

Type : II

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Chattem Chemicals Inc

USDMF

2024 ACI Convention

Not Confirmed

04

Chattem Chemicals Inc

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Fentanyl Citrate Usp

GDUFA

DMF Review : Complete

Rev. Date : 2014-03-15

Pay. Date : 2013-09-13

DMF Number : 23013

Submission : 2009-10-26

Status : Active

Type : II

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

05

Cody Laboratories Inc A Wholly Owned...

USDMF

2024 ACI Convention

Not Confirmed

05

Cody Laboratories Inc A Wholly Owned...

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Fentanyl Citrate Active Ingredient

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 17579

Submission : 2004-07-29

Status : Inactive

Type : II

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Curia Wisconsin Inc

USDMF

2024 ACI Convention

Not Confirmed

06

Curia Wisconsin Inc

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Fentanyl Citrate

GDUFA

DMF Review : Complete

Rev. Date : 2015-02-24

Pay. Date : 2014-02-05

DMF Number : 18178

Submission : 2005-03-14

Status : Active

Type : II

Product Web Link

Digital Content

Corporate PDF

07

Diosynth Bv

USDMF

2024 ACI Convention

Not Confirmed

07

Diosynth Bv

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Fentanyl Citrate

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 4751

Submission : 1983-01-04

Status : Inactive

Type : II

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Specgx Llc

USDMF

2024 ACI Convention

Not Confirmed

08

Specgx Llc

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Fentanyl Citrate (new Process)

GDUFA

DMF Review : Complete

Rev. Date : 2013-02-12

Pay. Date : 2012-11-27

DMF Number : 10128

Submission : 1993-03-15

Status : Active

Type : II

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Mallinckrodt Chemical Inc

USDMF

2024 ACI Convention

Not Confirmed

09

Mallinckrodt Chemical Inc

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Fentanyl Citrate Usp

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 7051

Submission : 1987-07-02

Status : Inactive

Type : II

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Penco Of Lyndhurst Inc

Country

USDMF

2024 ACI Convention

Not Confirmed

10

Penco Of Lyndhurst Inc

Country

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Fentanyl Citrate, Bulk Form

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 4752

Submission : 1983-01-06

Status : Inactive

Type : II

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2

Fentanyl Citrate Manufacturers | Traders | Suppliers

Fentanyl Citrate Manufacturers, Traders, Suppliers 1

48

We have 11 companies offering Fentanyl Citrate

Get in contact with the supplier of your choice:

Veranova
Abbott Laboratories
Boehringer Ingelheim GmbH
Cambrex Corporation
Chattem Chemicals, Inc
Cody Laboratories, Inc.
Curia
Fujifilm Diosynth Biotechnologies
Mallinckrodt Pharmaceuticals
Merck & Co
Yichang Humanwell Pharmaceutical

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?